Stocks · Health care · Biological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp

ADPT Clue Score44
United States Fiscal year ends December CIK 0001478320
26.49
+1.53%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
26.49 on 9 Oct 2026
30 21 12 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $15.50 14 Oct 2025 $15.58 15 Oct 2025 $17.11 16 Oct 2025 $17.27 17 Oct 2025 $16.30 20 Oct 2025 $17.83 21 Oct 2025 $17.35 22 Oct 2025 $16.45 23 Oct 2025 $17.16 24 Oct 2025 $17.22 27 Oct 2025 $17.12 28 Oct 2025 $16.90 29 Oct 2025 $16.80 30 Oct 2025 $16.91 31 Oct 2025 $17.36 3 Nov 2025 $17.34 4 Nov 2025 $16.92 5 Nov 2025 $17.59 6 Nov 2025 $15.56 7 Nov 2025 $14.79 10 Nov 2025 $14.71 11 Nov 2025 $14.53 12 Nov 2025 $14.50 13 Nov 2025 $14.14 14 Nov 2025 $14.10 17 Nov 2025 $13.71 18 Nov 2025 $13.75 19 Nov 2025 $15.15 20 Nov 2025 $16.32 21 Nov 2025 $18.61 24 Nov 2025 $20.46 25 Nov 2025 $20.32 26 Nov 2025 $19.72 28 Nov 2025 $19.66 1 Dec 2025 $18.84 2 Dec 2025 $18.69 3 Dec 2025 $17.13 4 Dec 2025 $17.46 5 Dec 2025 $14.75 8 Dec 2025 $14.95 9 Dec 2025 $14.86 10 Dec 2025 $15.74 11 Dec 2025 $15.42 12 Dec 2025 $15.44 15 Dec 2025 $15.69 16 Dec 2025 $15.93 17 Dec 2025 $16.12 18 Dec 2025 $16.50 19 Dec 2025 $17.00 22 Dec 2025 $17.41 23 Dec 2025 $16.75 24 Dec 2025 $16.68 26 Dec 2025 $16.70 29 Dec 2025 $16.65 30 Dec 2025 $16.42 31 Dec 2025 $16.24 2 Jan 2026 $15.91 5 Jan 2026 $16.17 6 Jan 2026 $16.11 7 Jan 2026 $16.73 8 Jan 2026 $15.96 9 Jan 2026 $15.76 12 Jan 2026 $18.26 13 Jan 2026 $18.07 14 Jan 2026 $18.04 15 Jan 2026 $17.78 16 Jan 2026 $17.52 20 Jan 2026 $17.87 21 Jan 2026 $17.57 22 Jan 2026 $19.06 23 Jan 2026 $18.55 26 Jan 2026 $19.12 27 Jan 2026 $19.23 28 Jan 2026 $18.50 29 Jan 2026 $18.37 30 Jan 2026 $18.50 2 Feb 2026 $18.39 3 Feb 2026 $18.50 4 Feb 2026 $17.30 5 Feb 2026 $16.47 6 Feb 2026 $15.77 9 Feb 2026 $15.86 10 Feb 2026 $15.64 11 Feb 2026 $15.62 12 Feb 2026 $15.54 13 Feb 2026 $16.04 17 Feb 2026 $15.79 18 Feb 2026 $15.87 19 Feb 2026 $16.05 20 Feb 2026 $15.20 23 Feb 2026 $15.39 24 Feb 2026 $16.05 25 Feb 2026 $16.21 26 Feb 2026 $16.46 27 Feb 2026 $16.02 2 Mar 2026 $16.12 3 Mar 2026 $16.08 4 Mar 2026 $16.44 5 Mar 2026 $15.93 6 Mar 2026 $14.86 9 Mar 2026 $14.95 10 Mar 2026 $14.52 11 Mar 2026 $14.22 12 Mar 2026 $12.45 13 Mar 2026 $13.17 16 Mar 2026 $13.32 17 Mar 2026 $13.39 18 Mar 2026 $13.28 19 Mar 2026 $13.50 20 Mar 2026 $13.58 23 Mar 2026 $13.66 24 Mar 2026 $13.90 25 Mar 2026 $14.15 26 Mar 2026 $13.96 27 Mar 2026 $12.41 30 Mar 2026 $12.85 31 Mar 2026 $13.88 1 Apr 2026 $14.43 2 Apr 2026 $14.81 6 Apr 2026 $14.08 7 Apr 2026 $13.71 8 Apr 2026 $14.84 9 Apr 2026 $13.40 10 Apr 2026 $12.79 13 Apr 2026 $14.13 14 Apr 2026 $14.53 15 Apr 2026 $14.53 16 Apr 2026 $14.08 17 Apr 2026 $14.47 20 Apr 2026 $14.58 21 Apr 2026 $14.21 22 Apr 2026 $14.20 23 Apr 2026 $13.82 24 Apr 2026 $14.14 27 Apr 2026 $14.21 28 Apr 2026 $14.04 29 Apr 2026 $13.53 30 Apr 2026 $14.10 1 May 2026 $14.27 4 May 2026 $14.50 5 May 2026 $13.78 6 May 2026 $14.43 7 May 2026 $14.69 8 May 2026 $13.81 11 May 2026 $13.54 12 May 2026 $13.63 13 May 2026 $13.13 14 May 2026 $13.18 15 May 2026 $12.83 18 May 2026 $12.71 19 May 2026 $12.96 20 May 2026 $13.96 21 May 2026 $13.87 22 May 2026 $13.88 26 May 2026 $14.13 27 May 2026 $13.84 28 May 2026 $15.19 29 May 2026 $15.15 1 Jun 2026 $15.23 2 Jun 2026 $15.14 3 Jun 2026 $15.99 4 Jun 2026 $18.08 5 Jun 2026 $16.90 8 Jun 2026 $16.70 9 Jun 2026 $17.36 10 Jun 2026 $17.07 11 Jun 2026 $18.73 12 Jun 2026 $17.60 15 Jun 2026 $17.46 16 Jun 2026 $17.22 17 Jun 2026 $16.78 18 Jun 2026 $17.53 22 Jun 2026 $17.37 23 Jun 2026 $17.23 24 Jun 2026 $19.34 25 Jun 2026 $20.25 26 Jun 2026 $20.96 29 Jun 2026 $21.40 30 Jun 2026 $21.45 1 Jul 2026 $22.37 2 Jul 2026 $21.19 6 Jul 2026 $21.50 7 Jul 2026 $20.82 8 Jul 2026 $20.16 9 Jul 2026 $21.80 10 Jul 2026 $21.06 13 Jul 2026 $21.02 14 Jul 2026 $21.43 15 Jul 2026 $22.90 16 Jul 2026 $22.10 17 Jul 2026 $22.92 20 Jul 2026 $21.86 21 Jul 2026 $22.58 22 Jul 2026 $21.95 23 Jul 2026 $22.31 24 Jul 2026 $22.27 27 Jul 2026 $22.54 28 Jul 2026 $22.52 29 Jul 2026 $22.56 30 Jul 2026 $24.18 31 Jul 2026 $22.57 3 Aug 2026 $23.11 4 Aug 2026 $24.55 5 Aug 2026 $24.60 6 Aug 2026 $23.60 7 Aug 2026 $24.93 10 Aug 2026 $25.45 11 Aug 2026 $25.39 12 Aug 2026 $25.25 13 Aug 2026 $24.46 14 Aug 2026 $24.74 17 Aug 2026 $24.77 18 Aug 2026 $24.56 19 Aug 2026 $25.49 20 Aug 2026 $25.44 21 Aug 2026 $25.99 24 Aug 2026 $25.55 25 Aug 2026 $26.25 26 Aug 2026 $26.16 27 Aug 2026 $26.44 28 Aug 2026 $25.19 31 Aug 2026 $24.92 1 Sep 2026 $24.34 2 Sep 2026 $24.66 3 Sep 2026 $24.57 4 Sep 2026 $24.28 8 Sep 2026 $24.34 9 Sep 2026 $24.42 10 Sep 2026 $24.23 11 Sep 2026 $24.20 14 Sep 2026 $24.78 15 Sep 2026 $26.68 16 Sep 2026 $27.67 17 Sep 2026 $28.55 18 Sep 2026 $28.61 21 Sep 2026 $27.86 22 Sep 2026 $28.06 23 Sep 2026 $27.89 24 Sep 2026 $29.57 25 Sep 2026 $29.43 28 Sep 2026 $28.51 29 Sep 2026 $28.77 30 Sep 2026 $28.90 1 Oct 2026 $27.37 2 Oct 2026 $28.35 5 Oct 2026 $29.84 6 Oct 2026 $26.90 7 Oct 2026 $26.28 8 Oct 2026 $26.09 9 Oct 2026 $26.49 ROBINS HARLAN S Chief Scientific Officer Sold on a plan $148.20K 10 Nov 2025 · at $14.82 · 0.8% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $1.27M 10 Nov 2025 · at $14.73 · 2.9% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $18.02K 11 Nov 2025 · at $14.57 · 0.0% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $28.01K 12 Nov 2025 · at $15.00 · 0.1% of stake PISKEL KYLE Chief Financial Officer Sold at will $3.34K 17 Nov 2025 · at $14.05 · 0.1% of stake BENZENO SHARON Chief Commercial Ofc Imm Med Sold on a plan $4.93M 20 Nov 2025 · at $16.54 · 50.1% of stake BENZENO SHARON Chief Commercial Ofc Imm Med Sold on a plan $5.22M 21 Nov 2025 · at $16.91 · 51.0% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $703.28K 26 Nov 2025 · at $19.68 · 1.2% of stake PISKEL KYLE Chief Financial Officer Sold on a plan $3.17M 28 Nov 2025 · at $19.50 · 42.9% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $2.37M 1 Dec 2025 · at $18.94 · 4.4% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $506.42K 3 Dec 2025 · at $18.61 · 2.1% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $166.10K 4 Dec 2025 · at $16.61 · 0.8% of stake BENZENO SHARON Chief Commercial Ofc Imm Med Sold on a plan $212.38K 4 Dec 2025 · at $16.85 · 4.1% of stake HERSHBERG ROBERT Director Sold at will $367.49K 10 Dec 2025 · at $16.00 · 33.0% of stake LO FRANCIS Chief People Officer Sold on a plan $1.77M 15 Dec 2025 · at $15.57 · 26.5% of stake LO FRANCIS Chief People Officer Sold on a plan $76.90K 22 Dec 2025 · at $17.50 · 1.4% of stake LO FRANCIS Chief People Officer Sold on a plan $50.25K 2 Jan 2026 · at $16.08 · 1.0% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $1.95M 5 Jan 2026 · at $15.59 · 4.6% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $164.40K 6 Jan 2026 · at $16.44 · 0.8% of stake PISKEL KYLE Chief Financial Officer Sold on a plan $77.22K 12 Jan 2026 · at $18.00 · 1.9% of stake LO FRANCIS Chief People Officer Sold on a plan $1.41M 12 Jan 2026 · at $17.73 · 20.1% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $644.82K 2 Feb 2026 · at $18.60 · 2.8% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $2.30M 2 Feb 2026 · at $18.44 · 4.8% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $154.28K 3 Feb 2026 · at $19.00 · 0.7% of stake PISKEL KYLE Chief Financial Officer Sold on a plan $39.60K 4 Feb 2026 · at $18.46 · 1.0% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $2.92M 27 Feb 2026 · at $15.99 · 7.4% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $157.20K 2 Mar 2026 · at $15.72 · 0.8% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $4.57M 2 Mar 2026 · at $15.82 · 12.7% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $235.13K 3 Mar 2026 · at $16.52 · 1.2% of stake RUBINSTEIN JULIE President and COO Sold on a plan $484.75K 3 Mar 2026 · at $15.67 · 5.0% of stake GRIFFIN MICHELLE RENEE Director Sold on a plan $735.07K 3 Mar 2026 · at $15.30 · 75.7% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $823.83K 3 Mar 2026 · at $15.52 · 2.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $513.62K 4 Mar 2026 · at $16.60 · 5.1% of stake RUBINSTEIN JULIE President and COO Sold on a plan $495.06K 5 Mar 2026 · at $16.00 · 5.1% of stake LO FRANCIS Chief People Officer Sold at will $574.54K 5 Mar 2026 · at $15.09 · 10.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $468.45K 6 Mar 2026 · at $15.14 · 4.5% of stake RUBINSTEIN JULIE President and COO Sold on a plan $457.62K 9 Mar 2026 · at $14.79 · 4.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $285.67K 10 Mar 2026 · at $14.68 · 2.9% of stake GRIFFIN MICHELLE RENEE Director Sold at will $214.13K 11 Mar 2026 · at $13.91 · 49.6% of stake PISKEL KYLE Chief Financial Officer Sold at will $245.91K 11 Mar 2026 · at $13.17 · 6.7% of stake LO FRANCIS Chief People Officer Sold on a plan $430.75K 11 Mar 2026 · at $14.08 · 9.5% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold at will $544.42K 11 Mar 2026 · at $13.17 · 8.8% of stake BENZENO SHARON Chief Commercial Ofc Imm Med Sold at will $831.07K 11 Mar 2026 · at $13.17 · 18.8% of stake RUBINSTEIN JULIE President and COO Sold on a plan $1.88M 11 Mar 2026 · at $13.29 · 21.5% of stake ROBINS CHAD M CEO and Chairman Sold at will $6.19M 11 Mar 2026 · at $13.17 · 17.0% of stake ROBINS HARLAN S Chief Scientific Officer Sold at will $6.19M 11 Mar 2026 · at $13.17 · 23.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $245.05K 12 Mar 2026 · at $12.86 · 3.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $247.02K 13 Mar 2026 · at $12.96 · 3.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $255.59K 16 Mar 2026 · at $13.41 · 3.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $255.40K 17 Mar 2026 · at $13.40 · 3.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $251.21K 18 Mar 2026 · at $13.18 · 3.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $251.21K 19 Mar 2026 · at $13.18 · 3.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $254.83K 20 Mar 2026 · at $13.37 · 3.8% of stake RUBINSTEIN JULIE President and COO Sold on a plan $263.60K 23 Mar 2026 · at $13.83 · 3.8% of stake RUBINSTEIN JULIE President and COO Sold on a plan $261.12K 24 Mar 2026 · at $13.70 · 3.8% of stake RUBINSTEIN JULIE President and COO Sold on a plan $271.99K 25 Mar 2026 · at $14.27 · 3.9% of stake RUBINSTEIN JULIE President and COO Sold on a plan $269.13K 26 Mar 2026 · at $14.12 · 3.9% of stake RUBINSTEIN JULIE President and COO Sold on a plan $254.22K 27 Mar 2026 · at $13.34 · 3.9% of stake RUBINSTEIN JULIE President and COO Sold on a plan $240.73K 30 Mar 2026 · at $12.63 · 4.0% of stake RUBINSTEIN JULIE President and COO Sold on a plan $256.36K 31 Mar 2026 · at $13.45 · 4.0% of stake RUBINSTEIN JULIE President and COO Sold on a plan $275.42K 1 Apr 2026 · at $14.45 · 4.1% of stake RUBINSTEIN JULIE President and COO Sold on a plan $278.28K 2 Apr 2026 · at $14.60 · 4.1% of stake RUBINSTEIN JULIE President and COO Sold on a plan $273.13K 6 Apr 2026 · at $14.33 · 4.1% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $1.20M 6 Apr 2026 · at $14.41 · 3.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $258.45K 7 Apr 2026 · at $13.56 · 4.2% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $148.50K 8 Apr 2026 · at $14.85 · 0.7% of stake LO FRANCIS Chief People Officer Sold on a plan $340.04K 8 Apr 2026 · at $15.07 · 7.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $458.92K 8 Apr 2026 · at $14.83 · 6.7% of stake ROBINS CHAD M CEO and Chairman Sold on a plan $566.02K 8 Apr 2026 · at $15.19 · 1.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $264.20K 9 Apr 2026 · at $13.86 · 4.2% of stake RUBINSTEIN JULIE President and COO Sold on a plan $243.31K 10 Apr 2026 · at $12.77 · 4.3% of stake RUBINSTEIN JULIE President and COO Sold on a plan $250.60K 13 Apr 2026 · at $13.15 · 4.3% of stake RUBINSTEIN JULIE President and COO Sold on a plan $277.51K 14 Apr 2026 · at $14.56 · 4.4% of stake RUBINSTEIN JULIE President and COO Sold on a plan $278.47K 15 Apr 2026 · at $14.61 · 4.4% of stake RUBINSTEIN JULIE President and COO Sold on a plan $270.27K 16 Apr 2026 · at $14.18 · 4.5% of stake RUBINSTEIN JULIE President and COO Sold on a plan $277.70K 17 Apr 2026 · at $14.57 · 4.5% of stake RUBINSTEIN JULIE President and COO Sold on a plan $277.32K 20 Apr 2026 · at $14.55 · 4.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $453.60K 21 Apr 2026 · at $14.66 · 7.3% of stake RUBINSTEIN JULIE President and COO Sold on a plan $269.32K 22 Apr 2026 · at $14.13 · 4.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $261.88K 23 Apr 2026 · at $13.74 · 4.7% of stake RUBINSTEIN JULIE President and COO Sold on a plan $267.22K 24 Apr 2026 · at $14.02 · 4.8% of stake RUBINSTEIN JULIE President and COO Sold on a plan $270.90K 27 Apr 2026 · at $14.23 · 4.8% of stake PISKEL KYLE Chief Financial Officer Sold at will $40.62K 18 May 2026 · at $13.04 · 1.2% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $198.00K 4 Jun 2026 · at $18.00 · 2.6% of stake LO FRANCIS Chief People Officer Sold on a plan $695.07K 4 Jun 2026 · at $17.49 · 13.7% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $95.00K 11 Jun 2026 · at $19.00 · 1.2% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $1.74M 15 Jun 2026 · at $17.37 · 6.6% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $110.94K 16 Jun 2026 · at $18.01 · 0.4% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $102.50K 25 Jun 2026 · at $20.50 · 1.2% of stake GRIFFIN MICHELLE RENEE Director Sold on a plan $1.05M 25 Jun 2026 · at $20.18 · 76.9% of stake BENZENO SHARON Chief Commercial Ofc Imm Med Sold on a plan $231.71K 26 Jun 2026 · at $21.00 · 3.9% of stake BENZENO SHARON Chief Commercial Ofc Imm Med Sold on a plan $3.27M 29 Jun 2026 · at $21.14 · 41.2% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $10.71K 1 Jul 2026 · at $22.00 · 0.1% of stake LO FRANCIS Chief People Officer Sold on a plan $1.14M 1 Jul 2026 · at $22.45 · 17.7% of stake LO FRANCIS Chief People Officer Sold on a plan $1.01M 2 Jul 2026 · at $22.59 · 16.3% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $8.50M 2 Jul 2026 · at $22.01 · 27.5% of stake LO FRANCIS Chief People Officer Sold on a plan $2.39M 15 Jul 2026 · at $22.59 · 31.4% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $115.00K 16 Jul 2026 · at $23.00 · 1.2% of stake ROBINS HARLAN S Chief Scientific Officer Sold on a plan $10.78M 21 Jul 2026 · at $21.89 · 37.7% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $31.18K 30 Jul 2026 · at $24.00 · 0.3% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $75.00K 10 Aug 2026 · at $25.00 · 0.8% of stake NEUPERT PETER M Director Sold at will $3.14M 17 Aug 2026 · at $25.15 · 48.8% of stake ROBINS CHAD M CEO and Chairman Sold at will $8.06M 17 Aug 2026 · at $25.08 · 12.8% of stake HERSHBERG ROBERT Director Sold at will $748.21K 18 Aug 2026 · at $24.40 · 39.6% of stake ROBINS CHAD M CEO and Chairman Sold at will $6.82M 18 Aug 2026 · at $24.48 · 11.3% of stake OWEN KATEY EINTERZ Director Sold at will $249.99K 26 Aug 2026 · at $26.00 · 10.9% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $32.27K 15 Sep 2026 · at $27.00 · 0.3% of stake LO FRANCIS Chief People Officer Sold on a plan $3.24M 16 Sep 2026 · at $28.06 · 34.3% of stake RUBINSTEIN JULIE President and COO Sold on a plan $333.30K 1 Oct 2026 · at $28.05 · 3.0% of stake LO FRANCIS Chief People Officer Sold on a plan $757.70K 1 Oct 2026 · at $28.28 · 10.8% of stake RUBINSTEIN JULIE President and COO Sold on a plan $334.21K 2 Oct 2026 · at $28.13 · 3.0% of stake RUBINSTEIN JULIE President and COO Sold on a plan $346.82K 5 Oct 2026 · at $29.19 · 3.0% of stake BOBULSKY SUSAN Chief Commercial Officer, MRD Sold on a plan $193.32K 6 Oct 2026 · at $30.00 · 1.6% of stake RUBINSTEIN JULIE President and COO Sold on a plan $329.70K 6 Oct 2026 · at $27.75 · 3.0% of stake RUBINSTEIN JULIE President and COO Sold on a plan $313.66K 7 Oct 2026 · at $26.40 · 3.0% of stake RUBINSTEIN JULIE President and COO Sold on a plan $304.87K 8 Oct 2026 · at $25.66 · 3.0% of stake
0 buys15 sales at will101 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$276.98M
Net income
$59.50M
Free cash flow
$48.95M
Operating margin
-20.6%
Net margin
-21.5%
Return on equity
-27.2%
Return on capital
-12.9%
Debt to equity
0.60
Revenue growth, 1 yr
54.8%
Revenue growth, 5 yr
23.0% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
98M -146M FY20 Fiscal year 2020 Revenue $98.38M Net income $146.23M Margin -148.6% 154M -207M FY21 Fiscal year 2021 Revenue $154.34M Net income $207.28M Margin -134.3% · growth +56.9% 185M -200M FY22 Fiscal year 2022 Revenue $185.31M Net income $200.19M Margin -108.0% · growth +20.1% 170M -225M FY23 Fiscal year 2023 Revenue $170.28M Net income $225.25M Margin -132.3% · growth -8.1% 179M -159M FY24 Fiscal year 2024 Revenue $178.96M Net income $159.49M Margin -89.1% · growth +5.1% 277M -59M FY25 Fiscal year 2025 Revenue $276.98M Net income $59.50M Margin -21.5% · growth +54.8%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
8 Oct 2026 RUBINSTEIN JULIE
President and COO
Sold on a plan $304.87K 3.0%
7 Oct 2026 RUBINSTEIN JULIE
President and COO
Sold on a plan $313.66K 3.0%
6 Oct 2026 RUBINSTEIN JULIE
President and COO
Sold on a plan $329.70K 3.0%
6 Oct 2026 BOBULSKY SUSAN
Chief Commercial Officer, MRD
Sold on a plan $193.32K 1.6%
5 Oct 2026 RUBINSTEIN JULIE
President and COO
Sold on a plan $346.82K 3.0%
2 Oct 2026 RUBINSTEIN JULIE
President and COO
Sold on a plan $334.21K 3.0%